Last reviewed · How we verify
NCT05290532
Effect of Multimodal Postoperative Rehabilitation on Functional and Cognitive Decline
NA trial testing Individualized exercise training in Surgery--Complications in 218 participants. Status unknown.
30 April 2024
Quick facts
| Lead sponsor | Hospital of Navarra |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 218 |
| Start date | 1 April 2022 |
| Primary completion | 30 April 2024 |
| Estimated completion | 1 April 2025 |
Drugs / interventions tested
- Individualized exercise training
Conditions studied
- Surgery--Complications — all drugs for Surgery--Complications →
Sponsor
Hospital of Navarra
Who can join
Adults 70 to 105, any sex, with Surgery--Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Older adults, especially those with frailty, have a higher risk for complications, functional and cognitive decline after urgent surgery. These patients have their functional and physiological reserve reduced which makes them more vulnerable to the effects of being bedridden. The consequences are at multiple levels emphasizing the functional loss or cognitive impairment, longer stays, mortality and institutionalization, delirium, poor quality of life and increased use of resources related to health. Exercise training can prevent functional and cognitive decline and modify even the posterior trajectory
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Postoperative physical rehabilitation in the elderly patient after emergency surgery. Influence on functional, cognitive and quality of live recovery: study protocol for a randomized clinical trial.
Esquiroz Lizaur I, Zambom-Ferraresi F, Zambom-Ferraresi F, Ollo-Martínez I, et al · · 2024 · cited 5× · PMID 39232792 · DOI 10.1186/s13063-024-08406-0 -
POSTOPERATIVE PHYSICAL REHABILITATION IN THE ELDERY PATIENT AFTER EMERGENCY SURGERY.
ESQU I, ZAMBON-FERRASI F, OLLO-MARTINEZ I, ZAMBON-FERRASI F, et al · · 2024 · DOI 10.21203/rs.3.rs-3864237/v1
Verify or expand the search:
- PubMed search for NCT05290532
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Surgery--Complications
Currently open trials in the same condition.
- NCT05219058 — Reconstruction in Extended MArgin Cancer Surgery · recruiting
- NCT04967391 — Tumescence in HNC Skin Graft Reconstruction · Phase 3 · active not recruiting
- NCT03561376 — Zinc Oxide Versus Petrolatum Following Skin Surgery · EARLY_PHASE1 · recruiting
- NCT05155878 — Prognostic Factors in Periampullary Tumors and Cysts · recruiting
- NCT04824066 — The Role of Wearable Devices in Cardiothoracic Surgery: Predicting and Detecting Early Postoperative Complications · recruiting
Other Hospital of Navarra trials
Trials by the same sponsor.
- NCT05216107 — Predicting Morbidity and Mortality in Elderly Surgical Patients · unknown
- NCT03860285 — Objective and Perceived Quality Study in Patients Undergoing Elective Groin Hernia Surgery · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05290532 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital of Navarra
- Last refreshed: 22 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05290532.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing